As for the laboratory test, although the serum AFP level in SH-HCC patients was significantly higher than for non-SH-HCC patients (p = 0.047), there were no significant differences in CA199, CEA, ALT, AST or T-Bil seen between the two groups (p > 0.05). This evidence concerns the gene GPT and hepatocellular carcinoma.